LCTX's logo.
Ticker Symbol: LCTX

Lineage Cell Therapeutics Inc

$2.44 - 20-12-2024 4 p.m. ET

Exchange: NYSE MKT LLC Country: US Currency: USD Asset Type: Common Stock CIK:0000876343

Company Profile

biotime, inc. is a clinical-stage biotechnology company focused on developing and commercializing novel therapies developed from what we believe to be the world's premier collection of pluripotent cell assets. the foundation of our core therapeutic technology platform is pluripotent cells that are capable of becoming any of the cell types in the human body. pluripotent cells have potential application in many areas of medicine with large unmet patient needs, including various age-related degenerative diseases and degenerative conditions for which there presently are no cures. unlike pharmaceuticals that require a molecular target, therapeutic strategies based on the use of pluripotent cells are generally aimed at regenerating or replacing affected cells and tissues, and therefore may have broader applicability than pharmaceutical products.

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 2173 Salk Ave Ste 200
CEO: Brian Culley
Tags:
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.11
Change: -$0.02 ( -1.77%)
Days Range: $1.10 - $1.14
Beta: 1.01
52wk. High: $1.58
52wk. Low: $1.03
Ytd. Change -5.19%
50 Day Moving Average: $1.27
200 Day Moving Average: $1.36
Shares Outstanding: 174986671

Valuation

Market Cap: 19.4B
PE Ratio: -8.57
EPS (TTM): -0.1295

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A